<p><iframe src="https://www.youtube.com/embed/YWDzvq5Hpr4" width="560" height="314" allowfullscreen="allowfullscreen"></iframe></p>
<h1 data-start="152" data-end="254">Conavi Medical&rsquo;s Mission to Transform Cardiovascular Imaging: A Conversation with CEO Thomas Looby</h1>
<h2 data-start="256" data-end="273">Introduction</h2>
<p data-start="274" data-end="736">Cardiovascular disease remains the world&rsquo;s leading cause of death, with millions of interventions performed every year. Yet, despite incredible progress, many procedures are still guided by limited imaging tools. In a recent episode of <em data-start="510" data-end="531">The Crux of MedTech</em> podcast, I sat down with <strong data-start="557" data-end="596">Thomas Looby, CEO of Conavi Medical</strong>, to discuss how his team is redefining intravascular imaging - and why the company is attracting serious investor and clinical attention.</p>
<hr data-start="738" data-end="741">
<h2 data-start="743" data-end="789">From Tech to MedTech: Tom Looby&rsquo;s Journey</h2>
<p data-start="790" data-end="1053">Looby&rsquo;s career didn&rsquo;t begin in healthcare. He first cut his teeth in technology and marketing before transitioning into medical devices. That early experience selling and integrating companies proved invaluable when he later took on leadership roles in medtech.</p>
<ul data-start="1055" data-end="1467">
<li data-start="1055" data-end="1175">
<p data-start="1057" data-end="1175">He led <strong data-start="1064" data-end="1081">Given Imaging</strong>, maker of the groundbreaking <em data-start="1111" data-end="1120">PillCam</em> endoscopic capsule, through acquisition by Covidien.</p>
</li>
<li data-start="1176" data-end="1291">
<p data-start="1178" data-end="1291">He ran a <strong data-start="1187" data-end="1218">robotic exoskeleton company</strong>, learning the unique challenges of commercialising disruptive medtech.</p>
</li>
<li data-start="1292" data-end="1467">
<p data-start="1294" data-end="1467">Today, as CEO of <strong data-start="1311" data-end="1329">Conavi Medical</strong>, he&rsquo;s steering the company&rsquo;s next-generation cardiovascular imaging platform toward market launch.</p>
</li>
</ul>
<p data-start="1469" data-end="1736">What has kept him in medtech? In his words, it&rsquo;s the <strong data-start="1522" data-end="1563">mission-driven connection to patients</strong> - reinforced by personal experiences, such as his father&rsquo;s heart event, which highlighted the shortcomings of existing imaging tools.</p>
<hr data-start="1738" data-end="1741">
<h2 data-start="1743" data-end="1804">The Problem: Outdated Imaging for Coronary Interventions</h2>
<p data-start="1805" data-end="2009">Every year, <strong data-start="1817" data-end="1844">4 million angiographies</strong> are performed to guide coronary interventions. These are essentially enhanced X-rays, useful but limited. To overcome those limitations, two technologies emerged:</p>
<ul data-start="2011" data-end="2230">
<li data-start="2011" data-end="2133">
<p data-start="2013" data-end="2133"><strong data-start="2013" data-end="2048">IVUS (Intravascular Ultrasound)</strong> - excellent for measuring vessel size and stent placement but lower in resolution.</p>
</li>
<li data-start="2134" data-end="2230">
<p data-start="2136" data-end="2230"><strong data-start="2136" data-end="2174">OCT (Optical Coherence Tomography)</strong> - superior resolution but weaker at depth and sizing.</p>
</li>
</ul>
<p data-start="2232" data-end="2500">Historically, physicians had to choose one, despite each having clear blind spots. As Looby explains, "doctors will only use one catheter during an intervention - either IVUS or OCT - and they&rsquo;re forced to accept the trade-offs".</p>
<hr data-start="2502" data-end="2505">
<h2 data-start="2507" data-end="2565">The Solution: Conavi&rsquo;s Dual-Modality Imaging Platform</h2>
<p data-start="2566" data-end="2782">Conavi Medical is the first company to successfully <strong data-start="2618" data-end="2665">combine IVUS and OCT into a single catheter</strong>, without compromising form factor or cost. This dual-modality system gives physicians the <strong data-start="2756" data-end="2779">best of both worlds</strong>:</p>
<ul data-start="2784" data-end="2956">
<li data-start="2784" data-end="2830">
<p data-start="2786" data-end="2830">Deep, reliable vessel measurements (IVUS).</p>
</li>
<li data-start="2831" data-end="2894">
<p data-start="2833" data-end="2894">High-resolution images for complex lesion assessment (OCT).</p>
</li>
<li data-start="2895" data-end="2956">
<p data-start="2897" data-end="2956">No additional cost compared to single-modality catheters.</p>
</li>
</ul>
<p data-start="2958" data-end="3211">The impact on clinical outcomes is profound. A recent <strong data-start="3012" data-end="3036">Lancet meta-analysis</strong> of 22 clinical trials showed that intravascular imaging can reduce <strong data-start="3104" data-end="3139">post-procedure mortality by 46%</strong> and <strong data-start="3144" data-end="3171">stent thrombosis by 52%.</strong></p>
<hr data-start="3213" data-end="3216">
<h2 data-start="3218" data-end="3249">Commercialisation Strategy</h2>
<p data-start="3250" data-end="3534">Conavi has already tested its first-generation platform in leading North American hospitals. With insights from those deployments, the <strong data-start="3385" data-end="3428">next-generation product is now complete</strong> and moving through FDA clearance, targeting <strong data-start="3473" data-end="3494">launch in Q3 2025.</strong></p>
<p data-start="3536" data-end="3576">Key steps in their commercial rollout:</p>
<ol data-start="3577" data-end="3861">
<li data-start="3577" data-end="3666">
<p data-start="3580" data-end="3666"><strong data-start="3580" data-end="3607">Early adopter hospitals</strong> - starting with those who trialled the first generation.</p>
</li>
<li data-start="3667" data-end="3737">
<p data-start="3670" data-end="3737"><strong data-start="3670" data-end="3699">Controlled feedback loops</strong> - refining usability and workflows.</p>
</li>
<li data-start="3738" data-end="3861">
<p data-start="3741" data-end="3861"><strong data-start="3741" data-end="3760">Global strategy</strong> - U.S. launch first, followed by Japan and Europe where reimbursement environments are favourable.</p>
</li>
</ol>
<hr data-start="3863" data-end="3866">
<h2 data-start="3868" data-end="3893">Financing and Growth</h2>
<p data-start="3894" data-end="4116">Conavi&rsquo;s quiet Canadian roots are quickly giving way to global recognition. After acquiring the assets of <strong data-start="4000" data-end="4017">Titan Medical</strong> (a Toronto-based surgical robotics pioneer), Conavi went public on the <strong data-start="4089" data-end="4113">TSX Venture Exchange</strong>.</p>
<p data-start="4118" data-end="4225">In April, the company raised <strong data-start="4147" data-end="4162">$20 million</strong>, far surpassing its $2&ndash;5 million target. Why? Investors saw:</p>
<ul data-start="4227" data-end="4438">
<li data-start="4227" data-end="4290">
<p data-start="4229" data-end="4290"><strong data-start="4229" data-end="4257">Strong clinical evidence</strong> backing intravascular imaging.</p>
</li>
<li data-start="4291" data-end="4359">
<p data-start="4293" data-end="4359"><strong data-start="4293" data-end="4320">Retired technology risk</strong>, with design verification completed.</p>
</li>
<li data-start="4360" data-end="4438">
<p data-start="4362" data-end="4438"><strong data-start="4362" data-end="4390">Clear regulatory pathway</strong>, with FDA pre-submission already in progress.</p>
</li>
</ul>
<p data-start="4440" data-end="4609">As Looby highlights, &ldquo;the only risk investors saw left was capital risk - and they helped us solve that with a much larger raise&rdquo;.</p>
<hr data-start="4611" data-end="4614">
<h2 data-start="4616" data-end="4663">Building for Acquisition - or Independence</h2>
<p data-start="4664" data-end="4715">Long-term, Conavi envisions two possible futures:</p>
<ul data-start="4717" data-end="4965">
<li data-start="4717" data-end="4798">
<p data-start="4719" data-end="4798"><strong data-start="4719" data-end="4741">Independent growth</strong> &ndash; commercialising directly and capturing market share.</p>
</li>
<li data-start="4799" data-end="4965">
<p data-start="4801" data-end="4965"><strong data-start="4801" data-end="4826">Strategic acquisition</strong> &ndash; being absorbed into a major player like Abbott, Boston Scientific, or Philips, who currently offer either IVUS <em data-start="4940" data-end="4944">or</em> OCT, but not both.</p>
</li>
</ul>
<p data-start="4967" data-end="5182">With only two acquirable imaging companies in this space - and Conavi the only one with dual-modality - the company is already positioning itself as a highly attractive target.</p>
<hr data-start="5184" data-end="5187">
<h2 data-start="5189" data-end="5227">Lessons for MedTech Entrepreneurs</h2>
<p data-start="5228" data-end="5329">Throughout the conversation, Looby shared insights relevant to any founder or executive in medtech:</p>
<ul data-start="5331" data-end="5694">
<li data-start="5331" data-end="5435">
<p data-start="5333" data-end="5435"><strong data-start="5333" data-end="5372">Market development must start early</strong> - don&rsquo;t rely solely on KOLs, broaden feedback before launch.</p>
</li>
<li data-start="5436" data-end="5583">
<p data-start="5438" data-end="5583"><strong data-start="5438" data-end="5476">Risk reduction drives acquisitions</strong> - the more regulatory, technical, and market risks you retire, the more attractive your company becomes.</p>
</li>
<li data-start="5584" data-end="5694">
<p data-start="5586" data-end="5694"><strong data-start="5586" data-end="5605">Mission matters</strong> - engineers and clinicians stay committed when they see the direct impact on patients.</p>
</li>
</ul>
<hr data-start="5696" data-end="5699">
<h2 data-start="5701" data-end="5716">Conclusion</h2>
<p data-start="5717" data-end="6005">Conavi Medical is on the cusp of reshaping how physicians approach coronary interventions. By eliminating trade-offs in intravascular imaging, their technology could set a new standard of care - while also positioning the company as a prime acquisition target in a consolidating market.</p>
<p data-start="6007" data-end="6207">As Looby says, <em data-start="6022" data-end="6168">&ldquo;We&rsquo;re the only company that can combine IVUS and OCT into the same catheter. That&rsquo;s exactly what the market needs &mdash; and what patients deserve.&rdquo;</em></p>

Thomas Looby

Dual-Modality Imaging That Rewrites PCI Outcomes with Thomas Looby

<p><iframe src="https://www.youtube.com/embed/as0ymTEs-9U" width="560" height="314" allowfullscreen="allowfullscreen"></iframe></p>
<h1 data-start="142" data-end="242">Why MedTech Can&rsquo;t Afford to Move Slow: Rethinking Healthcare&rsquo;s Culture of Caution</h1>
<p data-start="244" data-end="456">Healthcare is built on caution, but has the pendulum swung too far? Discover why MedTech innovation needs a new balance between safety and speed - and how patients stand to benefit most.</p>
<h3 data-start="463" data-end="481">Introduction</h3>
<p data-start="482" data-end="866">Healthcare innovation moves at a different pace than technology or AI - and for good reason. When lives are at stake, &ldquo;move fast and break things&rdquo; doesn&rsquo;t apply. But has the culture of caution gone too far? In this episode of the Cruxx Podcast, our guests unpack the tension between safety and speed in MedTech, exploring why patients ultimately pay the price when innovation drags.</p>
<hr data-start="868" data-end="871">
<h3 data-start="873" data-end="914">The Risk&ndash;Reward Curve in Healthcare</h3>
<p data-start="915" data-end="1169">Unlike internet or AI companies, healthcare operates on a far stricter risk&ndash;reward curve. Mistakes can&rsquo;t be patched with a software update - they can have real-world consequences for patients. This built-in caution is not only expected, it&rsquo;s essential.</p>
<p data-start="1171" data-end="1380">But here&rsquo;s the catch: too much caution slows down adoption of promising technologies. And in a field where time equals lives, the risk of doing nothing can be just as great as the risk of moving too quickly.</p>
<hr data-start="1382" data-end="1385">
<h3 data-start="1387" data-end="1436">When Safety Culture Becomes &ldquo;Check-the-Box&rdquo;</h3>
<p data-start="1437" data-end="1670">As one speaker explains, healthcare has drifted into a culture of <strong data-start="1503" data-end="1540">cover-your-assets decision-making</strong>. Instead of pushing innovation, many organizations default to legacy processes simply because &ldquo;it&rsquo;s always been done this way.&rdquo;</p>
<p data-start="1672" data-end="1854">This protects institutions from blame - but it also entrenches slow progress. The result? Patients who could benefit from faster access to breakthrough technology are left waiting.</p>
<hr data-start="1856" data-end="1859">
<h3 data-start="1861" data-end="1900">Patients as Stakeholders in Speed</h3>
<p data-start="1901" data-end="2230">The conversation emphasizes that the risk&ndash;reward curve doesn&rsquo;t just belong to regulators or corporations - it belongs to patients, too. While organizations see risk in moving fast, patients often see risk in moving too slow. For someone waiting for treatment or a life-changing device, innovation delayed is opportunity denied.</p>
<hr data-start="2232" data-end="2235">
<h3 data-start="2237" data-end="2265">Rethinking the Balance</h3>
<p data-start="2266" data-end="2546">The healthcare industry doesn&rsquo;t need to abandon caution - but it does need to recalibrate. Moving forward means building systems that encourage innovation without compromising patient safety. That&rsquo;s the only way MedTech can truly deliver on its promise: better outcomes, faster.</p>
<hr data-start="2548" data-end="2551">
<h3 data-start="2553" data-end="2586">Conclusion &amp; Call to Action</h3>
<p data-start="2587" data-end="2833">The Cruxx Podcast challenges the status quo: if innovation is possible, why let outdated caution stand in the way? It&rsquo;s time to rethink the culture of healthcare and design a future where patients benefit from speed, without sacrificing safety.</p>
<p data-start="2835" data-end="2922">👉 Listen to the <a href="https://www.youtube.com/watch?v=as0ymTEs-9U" target="_blank" rel="noopener">full episode</a> for deeper insights into MedTech&rsquo;s risk&ndash;reward balance.</p>
<p data-start="3721" data-end="3836">&nbsp;</p>

Sabine Bois

How to Survive FDA Battles and Boardroom Drama - with Sabine Bois

The MedTech Club — peer group for MedTech leaders

<h2 dir="ltr">What&rsquo;s Next for MedTech?&nbsp;</h2>
<h2 dir="ltr">-Dr. Dylan Attard, CEO, MedTech World</h2>
<p dir="ltr">The healthcare industry is entering a period of profound transformation. Once marked by incremental progress, today&rsquo;s medical technology landscape is evolving at an unprecedented pace. This momentum is not driven by a single innovation, but rather by the convergence of emerging technologies, increasing patient expectations, and a shifting global investment environment. The question is no longer what lies ahead for MedTech, but how quickly we can adapt to the changes already underway.</p>
<h3 dir="ltr">Robotics Expanding Beyond the Operating Room</h3>
<p dir="ltr">One of the most striking developments is the expanding role of robotics in healthcare. Traditionally associated with high-precision surgical interventions, robotics is now influencing nearly every aspect of care delivery. According to MarketsandMarkets, the global medical robots market&mdash;valued at $16.0 billion in 2024&mdash;is projected to reach $33.8 billion by 2029, reflecting a compound annual growth rate of over 16%. This growth is not confined to the operating room. Robotic systems are being deployed for rehabilitation, delivering personalized therapy and speeding up patient recovery, while automation technologies are streamlining hospital logistics, pharmacy operations, and infection control. Far from replacing clinicians, these tools are designed to extend their capabilities, reduce strain, and improve clinical workflows.</p>
<p><strong>&nbsp;</strong></p>
<h3 dir="ltr">AI and Connectivity: Driving Intelligent Care</h3>
<p dir="ltr">Artificial intelligence is rapidly becoming an integral part of healthcare&rsquo;s digital backbone. Initially applied to diagnostics, AI is now enabling more personalized treatment planning, facilitating earlier detection of disease progression, and accelerating the development of new therapies. With a market forecast to grow from $26.69 billion in 2024 to over $613 billion by 2034, AI's integration into medical practice is expected to deepen across both clinical and operational domains. Notably, AI is also playing a critical role in enhancing robot-assisted procedures, further reinforcing its presence within the MedTech ecosystem.</p>
<p dir="ltr">Connectivity is another area seeing exponential growth. The rise of the Internet of Medical Things (IoMT) is enabling real-time patient monitoring, remote diagnostics, and continuous data exchange between patients and providers. As a result, interventions are becoming more timely and proactive, contributing to better outcomes. The global IoMT market is expected to exceed one trillion dollars by 2034, up from $242.80 billion in 2024. This growth reflects the mounting demand for integrated, efficient systems that extend care beyond traditional clinical settings.</p>
<p><strong>&nbsp;</strong></p>
<h3 dir="ltr">Personal Health, Precision, and Immersive Technologies</h3>
<p dir="ltr">Wearable health technologies are gaining traction by giving individuals greater control over their health. From basic fitness trackers to advanced biosensors, these tools are fostering a more engaged, data-driven approach to personal wellbeing. Virtual and augmented reality technologies are also reshaping clinical education, surgical simulation, and even pain management strategies, bringing immersive solutions into both hospitals and training centers.</p>
<p dir="ltr">Another major frontier lies in precision medicine. Advances in genomics and pharmacogenomics are enabling treatments that align more closely with individual biological profiles, offering improved outcomes and reducing the risk of adverse effects. This shift from a one-size-fits-all approach to highly personalized care is redefining what effective medicine looks like in the 21st century.</p>
<p dir="ltr">Sustainability, meanwhile, is becoming a growing priority across the industry. As awareness of healthcare&rsquo;s environmental impact grows, many companies are embracing eco-conscious manufacturing processes and circular economy principles. Responsible innovation will not only shape the future of MedTech but also ensure its alignment with broader global goals.</p>
<p><strong>&nbsp;</strong></p>
<h3 dir="ltr">Investment Confidence and Market Consolidation</h3>
<p dir="ltr">Despite global economic uncertainties, MedTech continues to attract investor interest. In 2024, venture capital funding surpassed the previous year&rsquo;s total, reaching $19.1 billion across nearly 700 deals. Investor confidence appears resilient, though more selective, with capital increasingly concentrated in high-impact areas such as digital health, robotics, and AI-driven platforms.</p>
<p dir="ltr">Mergers and acquisitions are also on the rise. The industry recorded 305 M&amp;A transactions in 2024, the second-highest count in a decade. Larger players are actively seeking to expand product portfolios, access new capabilities, and increase operational efficiency. Johnson &amp; Johnson&rsquo;s $13.1 billion acquisition of Shockwave Medical is one of several headline deals highlighting renewed interest in consolidation. The uptick in acquisitions of venture-backed companies further suggests that a healthy exit environment is returning for startups.</p>
<p dir="ltr">Alongside investment activity, regulatory engagement is also evolving. Authorities are taking a more collaborative approach with innovators, helping to shape ethical frameworks for the adoption of new technologies while streamlining approval processes. This closer alignment is expected to facilitate faster yet safer go-to-market strategies for emerging solutions.</p>
<p><strong>&nbsp;</strong></p>
<h3 dir="ltr">Looking Ahead: Collaboration Will Define Progress</h3>
<p dir="ltr">What emerges from this landscape is a MedTech industry defined not solely by invention, but by meaningful integration. The real opportunity lies in how these technologies converge to improve patient care, empower clinicians, and make healthcare more efficient, accessible, and sustainable.</p>
<p dir="ltr">At <a href="https://med-tech.world/medtech-malta-2025/?utm_source=web&amp;utm_medium=post&amp;utm_campaign=opinionated-piece" target="_blank" rel="noopener">MedTech World</a>, we are committed to advancing this future. From November 12 to 14, 2025, we will bring together leaders, startups, investors, and global stakeholders at <a href="https://med-tech.world/medtech-malta-2025/?utm_source=web&amp;utm_medium=post&amp;utm_campaign=opinionated-piece" target="_blank" rel="noopener">MedTech Malta 2025</a>. Held in the historic city of Valletta, this three-day gathering will offer attendees the chance to engage with transformative ideas, forge new partnerships, and explore the innovations actively shaping the next era of healthcare.</p>
<p dir="ltr">In a time of accelerating change, understanding the direction of MedTech has never been more essential. We invite you to be part of that conversation.</p>
<p dir="ltr"><img src="db886051-acfa-4270-9b2a-8f9f76749e13" alt=""></p>
<p>&nbsp;</p>

What’s Next for MedTech?

<p>A Search Firm Placing MedTech Pioneers in Transformative Roles to help us live longer healthier lives.</p>

About us

We are

<span>Changemakers</span>

<span>Impactful</span>

<p>Cruxx is a search firm that supports the most innovative healthcare companies on the planet. With a global focus and a team of deep sector experts, we are building the search firm for the modern day.</p>

<p class="h2">Our vision is a future of life-saving innovation. We help <span class="text--primary">accelerate medical technology</span> to a point that fringes on science fiction. We <span class="text--primary">advocate</span> for a new age of surgery to turn today&rsquo;s MedTech ideas into reality.</p>

<p>Meet the team</p>

Inspire and excite. Avoid fluff. Be clear, direct and transparent. Strip things to the base layer to build intentional, authentic relationships with partners.

We are relentless in our pursuit.

<span>Relentless</span>

<span>Purposeful</span>

We are purposeful.

<p>We're always on the hunt for talented people who thrive on building committed connections. We are curious, energetic, driven, open-minded, innovative, and lovers of learning, so if that sounds like you, you know just what to do.</p>

Careers

<h2>Be the changemaker</h2><p>&nbsp;</p><p>We're always on the hunt for talented people who thrive on building committed connections. We are curious, energetic, driven, open-minded, innovative, and lovers of learning, so if that sounds like you, you know just what to do.&nbsp;</p><p><a class="outlineBtn mt-3" href="/submit-your-cv/">Send your CV</a></p>

<p>Perks</p>

<p></p>

Contact CruxX

EXPLORE OUR INSIGHTS OR THE SURGIBOTS PODCAST

You have a thirst to learn about the latest medical innovation 

<p>Explore our Vacancies</p>

YOU WANT A MISSION, NOT A JOB.

You want to find a place to grow

YOU HAVE A PROBLEM TO SOLVE

You want to Hire the best people for your MedTech Mission 

<span class="text--white">MedTech Search at the</span> <span class="text--primary">Cutting Edge</span>

<p>You're Probably Here for 1 of 3 reasons</p>

<p>We place MedTech pioneers in leading companies to solve the world&rsquo;s biggest health problems.</p>

<p>Companies who are addressing the world’s biggest health <br>challenges through innovation.</p>

<h2 class="text--primary">Cruxx are the experts in building <br>and scaling MedTech companies.</h2>

<p>Our recruitment solutions</p>

<span>Cruxx are the experts in building and scaling MedTech companies.</span>

<span>Companies who are addressing the world’s biggest health challenges through innovation.</span>

<p>Stay up to date with the latest Cruxx news</p>

Sign up for industry content

<p><small>We specialise in matching pioneering talent with leading companies in the MedTech sector to address the world’s most pressing health challenges. Cruxx operates globally with a commitment to innovation, placing the aspirations and needs of our clients and candidates at the heart of our approach. We don’t just fill roles; we forge connections, facilitate breakthroughs, and fuel progress in medical technology and healthcare.</small></p>

Testimonials

<p>At Cruxx we are at the cutting edge of MedTech search. Working with innovators, to hire the talent who are bringing medical innovation to the world.</p>

We're Hiring

<p>At Cruxx, we understand the vast potential and intricate nuances of the MedTech sector. We have our fingers on the pulse of the latest advancements and opportunities worldwide. We pride ourselves on offering a personalised experience. Every person we work with is unique, and we tailor our approach to match their distinct aspirations and needs.</p><p>The world of medical technology is not just about devices and data; it's about real-world</p>

<p>impact on health outcomes. When you partner with Cruxx, you're aligning with a team that's deeply committed to addressing the world's most pressing health challenges.</p><p>At Cruxx, we believe in the power of meaningful connections. We're not just filling roles; we're building bridges between pioneering talent and leading companies. Choose Cruxx, and be part of a journey that redefines the future of healthcare.</p>

<p><small>Take a look at what our clients say...</small></p>

Don’t take our word for it

<p>Case Studies</p>

<h3 data-start="333" data-end="353"><strong data-start="337" data-end="351">Who We Are</strong></h3>
<h5 data-start="354" data-end="579">The&nbsp;<strong data-start="358" data-end="374">MedTech Club</strong>&nbsp;is an exclusive community of medical technology leaders &mdash; CEOs, investors, and industry experts &mdash; united by a shared mission: to accelerate innovation, collaboration, and growth in the MedTech industry.</h5>
<p>&nbsp;</p>
<h3 data-start="581" data-end="604"><strong data-start="585" data-end="602">What We Offer</strong></h3>
<ul data-start="605" data-end="1049">
<li data-start="605" data-end="721">
<h5><strong data-start="607" data-end="641">Peer-to-Peer Knowledge Sharing</strong>&nbsp;&ndash; Learn from the experiences of other leaders navigating the same challenges.</h5>
</li>
<li data-start="605" data-end="721">
<h5><strong data-start="724" data-end="757">Collaborative Problem-Solving</strong>&nbsp;&ndash; Tackle industry obstacles together with insights from diverse perspectives.</h5>
</li>
<li data-start="838" data-end="940">
<h5><strong data-start="840" data-end="868">Networking Opportunities</strong>&nbsp;&ndash; Build meaningful connections with peers, investors, and innovators.</h5>
</li>
<li data-start="941" data-end="1049">
<h5><strong data-start="943" data-end="971">Monthly Virtual Meetings</strong>&nbsp;&ndash; Engage in high-value discussions with a curated group of decision-makers.</h5>
</li>
</ul>
<h3 data-start="1051" data-end="1075">&nbsp;</h3>
<h3 data-start="1051" data-end="1075"><strong data-start="1055" data-end="1073">Why It Matters</strong></h3>
<h5>We believe that&nbsp;<strong data-start="1092" data-end="1125">a strong, connected community</strong>&nbsp;can:</h5>
<ul data-start="1133" data-end="1266">
<li data-start="1133" data-end="1163">
<h5>Accelerate business growth</h5>
</li>
<li data-start="1164" data-end="1198">
<h5>Enhance industry collaboration</h5>
</li>
<li data-start="1199" data-end="1266">
<h5>Support emerging MedTech companies in overcoming key challenges</h5>
</li>
</ul>
<h3 data-start="1268" data-end="1288">&nbsp;</h3>
<h3 data-start="1268" data-end="1288"><strong data-start="1272" data-end="1286">Our Vision</strong></h3>
<h5 data-start="1289" data-end="1381">We&rsquo;re just getting started. In the coming months, the MedTech Club will expand to include:</h5>
<ul data-start="1382" data-end="1707">
<li data-start="1382" data-end="1434">
<h5 data-start="1384" data-end="1434"><strong data-start="1384" data-end="1408">Multiple Peer Groups</strong>&nbsp;for focused discussions</h5>
</li>
<li data-start="1435" data-end="1483">
<h5 data-start="1437" data-end="1483"><strong data-start="1437" data-end="1457">In-Person Events</strong>&nbsp;to deepen relationships</h5>
</li>
<li data-start="1484" data-end="1547">
<h5 data-start="1486" data-end="1547"><strong data-start="1486" data-end="1510">Structured Resources</strong>&nbsp;for continuous professional growth</h5>
</li>
<li data-start="1548" data-end="1638">
<h5 data-start="1550" data-end="1638"><strong data-start="1550" data-end="1603">Integration with Recruitment &amp; Investment Banking</strong>&nbsp;to unlock business opportunities</h5>
</li>
<li data-start="1639" data-end="1707">
<h5 data-start="1641" data-end="1707"><strong data-start="1641" data-end="1667">Potential Monetization</strong>&nbsp;to reinvest in the community&rsquo;s growth</h5>
</li>
</ul>
<h3 data-start="1709" data-end="1740">&nbsp;</h3>
<h3 data-start="1709" data-end="1740"><strong data-start="1713" data-end="1738">Join the Conversation</strong></h3>
<h5 data-start="1741" data-end="1878">If you&rsquo;re a leader shaping the future of MedTech, the MedTech Club is your platform to connect, collaborate, and create lasting impact.</h5>
<h5 data-start="1741" data-end="1878">Book a time with Henry, click&nbsp;<a href="https://my.recruitwithatlas.com/Cruxx/Henry-Norton/The-MedTech-Club-Discovery-Call" target="_blank" rel="noopener">HERE</a>.</h5>

The MedTech Club

The MedTech Club

Who We Are

The MedTech Club is an exclusive community of medical technology leaders — CEOs, investors, and industry experts — united by a shared mission: to accelerate innovation, collaboration, and growth in the MedTech industry.

What We Offer

Peer-to-Peer Knowledge Sharing – Learn from the experiences of other leaders navigating the same challenges.

Collaborative Problem-Solving – Tackle industry obstacles together with insights from diverse perspectives.

Networking Opportunities – Build meaningful connections with peers, investors, and innovators.

Monthly Virtual Meetings – Engage in high-value discussions with a curated group of decision-makers.

Why It Matters

We believe that a strong, connected community can:

Accelerate business growth

Enhance industry collaboration

Support emerging MedTech companies in overcoming key challenges

Our Vision

We’re just getting started. In the coming months, the MedTech Club will expand to include:

Multiple Peer Groups for focused discussions

In-Person Events to deepen relationships

Structured Resources for continuous professional growth

Integration with Recruitment & Investment Banking to unlock business opportunities

Potential Monetization to reinvest in the community’s growth

Join the Conversation

If you’re a leader shaping the future of MedTech, the MedTech Club is your platform to connect, collaborate, and create lasting impact.

Book a time with Henry, click HERE.

Discover more about Medical Devices